Evidence map›Paper›PMID 37258414›Full record

ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.

Cyrus Chargari, Kari Tanderup, François Planchamp, Luis Chiva, Pauline Humphrey, Alina Sturdza, Li T Tan, Elzbieta van der Steen-Banasik, Ignacio Zapardiel, Remi A Nout and 1 more

Abstract read
In one paragraph

Article in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The clinical application of in vivo dosimetry for gynaecological brachytherapy: A scoping review.Technical innovations & patient support in radiation oncology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cyrus ChargariInstitut Gustave-Roussy, Villejuif, France cyrus.chargari@gustaveroussy.fr.
Kari TanderupAarhus University Hospital, Aarhus, Denmark.
François PlanchampClinical Research Unit, Institut Bergonie, Bordeaux, France.ORCID 0000-0002-8709-0410
Luis ChivaObstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain.ORCID 0000-0002-1908-3251
Pauline HumphreyUniversity Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Alina SturdzaDepartment of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Wien, Austria.
Li T TanAddenbrooke's Hospital, Cambridge, UK.
Elzbieta van der Steen-BanasikRadiotherapie Groep/Arnhem, Arnhem, The Netherlands.
Ignacio ZapardielGynecologic Oncology, La Paz University Hospital, Madrid, Spain.ORCID 0000-0002-9175-7767
Remi A NoutRadiotherapy, Erasmus MC Cancer Centre, Rotterdam, Netherlands.
Christina FotopoulouGynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK.ORCID 0000-0001-6375-9645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe European Society of Gynaecological Oncology (ESGO) has previously defined and established a list of quality indicators for the surgical treatment of cervical cancer. As a continuation of this effort to improve overall quality of care for cervical cancer patients across all aspects, ESGO and the European SocieTy for Radiotherapy and Oncology (ESTRO) initiated the development of quality indicators for radiation therapy of cervical cancer.

objectiveTo develop a list of quality indicators for radiation therapy of cervical cancer that can be used to audit and improve clinical practice by giving to practitioners and administrators a quantitative basis to improve care and organizational processes, notably for recognition of the increased complexity of modern external radiotherapy and brachytherapy techniques.

methodsQuality indicators were based on scientific evidence and/or expert consensus. The development process included a systematic literature search for identification of potential quality indicators and documentation of scientific evidence, consensus meetings of a group of international experts, an internal validation process, and external review by a large international panel of clinicians (n=99).

resultsUsing a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are detailed to define how the quality indicators will be measured in practice. Targets were also defined for specifying the level which each unit or center should be aiming to achieve. Nineteen structural, process, and outcome indicators were defined. Quality indicators 1-6 are general requirements related to pretreatment workup, time to treatment, upfront radiation therapy, and overall management, including active participation in clinical research and the decision making process within a structured multidisciplinary team. Quality indicators 7-17 are related to treatment indicators. Quality indicators 18 and 19 are related to patient outcomes. DISCUSSION: This set of quality indicators is a major instrument to standardize the quality of radiation therapy in cervical cancer. A scoring system combining surgical and radiotherapeutic quality indicators will be developed within an envisaged future ESGO accreditation process for the overall management of cervical cancer, in an effort to support institutional and governmental quality assurance programs.

Indexed as

Radiation OncologyUterine Cervical NeoplasmsFemaleHumansMedical OncologyQuality Indicators, Health Carecervical cancer

Identifiers

PMID37258414
PMCPMC10313976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.